Young adults with MSUD and their transition to adulthood: psychosocial issues
- PMID: 22350623
- DOI: 10.1007/s10897-012-9490-1
Young adults with MSUD and their transition to adulthood: psychosocial issues
Abstract
Maple Syrup Urine Disease (MSUD) is an autosomal recessive condition with an incidence of 1 in 185,000 births worldwide. Regardless of the type of MSUD, treatment includes immediate and lifelong dietary restriction of isoleucine, leucine and valine. There is little known about the psychosocial impact of MSUD on the developmental milestones of emerging adulthood. We used a qualitative case study approach to explore the human experiences of MSUD on young adults (n = 8) and parents (n = 8). All participants were administered a semi-structured, qualitative interview as well as quantitative measures. Six core themes emerged: 1) lifelong strain of dietary management; 2) social isolation from peers and impact on dating; 3) impact of MSUD on academics and employment; 4) medical experiences and transition to adult care; 5) impact on family functioning; and 6) positive effects and growth. The results of this investigation highlight and expand awareness of the psychological and social needs of young adults with MSUD. This study calls for a collaborative, multidisciplinary effort in the treatment of these patients and their families.
Similar articles
-
Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.J Inherit Metab Dis. 2017 Nov;40(6):783-792. doi: 10.1007/s10545-017-0083-x. Epub 2017 Sep 13. J Inherit Metab Dis. 2017. PMID: 28905140
-
Psychosocial issues in families affected by maple syrup urine disease.J Genet Couns. 2007 Dec;16(6):799-809. doi: 10.1007/s10897-007-9114-3. Epub 2007 Aug 17. J Genet Couns. 2007. PMID: 17703353
-
Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients.Int J Pharm. 2019 Aug 15;567:118497. doi: 10.1016/j.ijpharm.2019.118497. Epub 2019 Jul 4. Int J Pharm. 2019. PMID: 31279771 Clinical Trial.
-
Successful pregnancy in maple syrup urine disease: a case report and review of the literature.Nutr J. 2018 May 12;17(1):51. doi: 10.1186/s12937-018-0357-7. Nutr J. 2018. PMID: 29753318 Free PMC article. Review.
-
[Gene analysis of maple syrup urine disease (MSUD)].Rinsho Byori. 1993 May;41(5):484-91. Rinsho Byori. 1993. PMID: 8350511 Review. Japanese.
Cited by
-
[Evaluation and optimization of newborn screening by structured long-term follow-up-using the example of inherited metabolic diseases].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Nov;66(11):1249-1258. doi: 10.1007/s00103-023-03772-7. Epub 2023 Oct 10. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023. PMID: 37815612 Free PMC article. Review. German.
-
Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.Hum Mol Genet. 2014 Sep 15;23(R1):R1-8. doi: 10.1093/hmg/ddu123. Epub 2014 Mar 20. Hum Mol Genet. 2014. PMID: 24651065 Free PMC article. Review.
-
Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocates.Patient. 2015 Feb;8(1):75-84. doi: 10.1007/s40271-014-0096-6. Patient. 2015. PMID: 25362528
-
Oral health status of children and young adults with maple syrup urine disease in Turkey.BMC Oral Health. 2021 Jan 6;21(1):8. doi: 10.1186/s12903-020-01376-0. BMC Oral Health. 2021. PMID: 33407387 Free PMC article.
-
Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review.Orphanet J Rare Dis. 2014 Oct 25;9:159. doi: 10.1186/s13023-014-0159-8. Orphanet J Rare Dis. 2014. PMID: 25344299 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources